Atlas Legacy Advisors, LLC

Position in NVS — Novartis AG

CIK 2054111 LOS ANGELES, CA

Position in NVS

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$280,215

New position

Shares Held

1,788

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#1,171

of 1,603 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 83% Shared 17% None 0%

Healthcare · as of Jun 30, 2026

Atlas Legacy Advisors, LLC holds $5,121,297 across 6 Drug Manufacturers - General names. NVS ranks #6 (5.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,579	$1,893,899
2	JNJ	Johnson & Johnson	4,361	$1,107,562
3	ABBV	AbbVie Inc.	2,607	$656,025
4	AMGN	Amgen Inc	1,644	$595,324
5	MRK	Merck & Co., Inc.	4,578	$588,272
6	NVS	Novartis AG This page	1,788	$280,215

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$280,215	1,788	—	Shares	Sole	2026-07-31
No filing history on record for this holder in this stock.